PAR •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 09:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangePAR
Market Capitalization6.1 mln
Float17.38 mln
EPS
0.30
Marginal
P / E
1.06
Deeply undervalued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.34
Borderline
Relative Strength
66
/ 100
Outperforming
Debt / Equity
0.12
Very low leverage
Business Description
Founded in 1995 and headquartered in Dijon, France, Oncodesign Precision Medicine is a biopharmaceutical company developing targeted therapies for serious diseases including cancer, inflammatory bowel disease, and Parkinson's disease. Its lead drug candidates work by blocking specific proteins linked to disease progression, while a separate line of research focuses on molecules that can both detect and treat advanced digestive and pancreatic cancers in a single approach.
